Publications by authors named "Meir Azulay"

Claim this Profile
T
Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading.
Meir Azulay, Michal Shahar, Eitan Shany, Eti Elbaz, Sveta Lifshits

J Transl Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2).
Julia Huetter, Uwe Gritzan, Ilona Gutcher, Wolf-Dietrich Doecke, Merlin V Luetke-Eversloh, Meir Azulay

Cancer Immunol Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mouse PVRIG Has CD8 T Cell-Specific Coinhibitory Functions and Dampens Antitumor Immunity.
Benjamin Murter, Xiaoyu Pan, Eran Ophir, Zoya Alteber, Meir Azulay

Cancer Immunol Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.
Zoya Alteber, Meir Azulay, Gal Cafri, Ezra Vadai, Esther Tzehoval

Cancer Immunol Immunother· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells.
Ilan Volovitz, Yotvat Marmor, Meir Azulay, Arthur Machlenkin, Ofir Goldberger

J Immunol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis